Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
Atea Pharmaceuticals, Inc. (AVIR) had Free Cash Flow of $-135.50M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-168.38M |
|
-- |
|
-- |
|
$192.95M |
|
$-192.95M |
|
$25.49M |
|
$-167.46M |
|
$-167.46M |
|
$-168.38M |
|
$-168.38M |
|
$-168.38M |
|
$-168.38M |
|
$-192.95M |
|
$-204.35M |
|
84.26M |
|
84.26M |
|
$-2.00 |
|
$-2.00 |
|
| Balance Sheet Financials | |
$462.36M |
|
$0.87M |
|
$2.31M |
|
$464.67M |
|
$18.60M |
|
-- |
|
$7.20M |
|
$25.80M |
|
$438.87M |
|
$438.87M |
|
$438.87M |
|
84.46M |
|
| Cash Flow Statement Financials | |
$-135.50M |
|
$56.10M |
|
$0.27M |
|
$143.82M |
|
$64.70M |
|
$-79.13M |
|
$51.77M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
24.85 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Free Cash Flow |
$-135.50M |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-38.37% |
|
-38.37% |
|
-36.24% |
|
-38.37% |
|
$5.20 |
|
$-1.61 |
|
$-1.61 |
|